Compare Mochida Pharmaceutical Co., Ltd. with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROE of 5.66%
- The company has been able to generate a Return on Equity (avg) of 5.66% signifying low profitability per unit of shareholders funds
2
Weak Long Term Fundamental Strength with a -6.29% CAGR growth in Operating Profits over the last 5 years
3
Poor long term growth as Net Sales has grown by an annual rate of 1.76% and Operating profit at -6.29% over the last 5 years
4
Positive results in Jun 26
5
With ROE of 4.67%, it has a attractive valuation with a 0.83 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
JPY 114,265 Million (Small Cap)
18.00
NA
0.00%
-0.15
5.64%
0.81
Revenue and Profits:
Net Sales:
31,719 Million
(Quarterly Results - Jun 2026)
Net Profit:
3,178 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.41%
0%
-6.41%
6 Months
-12.05%
0%
-12.05%
1 Year
-0.62%
0%
-0.62%
2 Years
0.78%
0%
0.78%
3 Years
1.1%
0%
1.1%
4 Years
-6.28%
0%
-6.28%
5 Years
-8.15%
0%
-8.15%
Mochida Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
1.76%
EBIT Growth (5y)
-6.29%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
0.80
Tax Ratio
29.25%
Dividend Payout Ratio
35.89%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.05%
ROE (avg)
5.66%
Valuation key factors
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
0.83
EV to EBIT
9.78
EV to EBITDA
7.23
EV to Capital Employed
0.78
EV to Sales
0.73
PEG Ratio
1.74
Dividend Yield
NA
ROCE (Latest)
7.94%
ROE (Latest)
4.67%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
Jun'26
Jun'25
Change(%)
Net Sales
31,719.00
26,631.00
19.11%
Operating Profit (PBDIT) excl Other Income
4,295.00
3,269.00
31.39%
Interest
43.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
3,178.00
1,894.00
67.79%
Operating Profit Margin (Excl OI)
112.40%
96.60%
1.58%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2026 is 19.11% vs 4.82% in Jun 2025
Consolidated Net Profit
YoY Growth in quarter ended Jun 2026 is 67.79% vs 21.88% in Jun 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
116,951.00
105,159.00
11.21%
Operating Profit (PBDIT) excl Other Income
13,127.00
11,067.00
18.61%
Interest
72.00
3.00
2,300.00%
Exceptional Items
-24.00
0.00
Consolidate Net Profit
7,903.00
5,685.00
39.01%
Operating Profit Margin (Excl OI)
86.80%
77.30%
0.95%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 11.21% vs 2.21% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is 39.01% vs 25.03% in Mar 2025
About Mochida Pharmaceutical Co., Ltd. 
Mochida Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






